1-(3-Methoxyphenyl)piperazine Dihydrochloride, Nimewo CAS se 6968-76-9, ki se yon entèmedyè Letermovir.
| Non pwodwi | 1-(3-Methoxyphenyl)piperazine Dihydrochloride |
|
Nimewo CAS |
6968-76-9 |
|
Pite |
Pi gran pase oswa egal a 98% |
|
Enpurte total |
Mwens pase oswa egal a 2% |
|
Single enpurte |
Mwens pase oswa egal a 0.5% |
|
Fòmil molekilè |
C11H17ClN2O |
|
Pwa molekilè |
228.72 |
|
Retest peryòd |
12 mwa |
|
Kondisyon Depo |
Sele nan sèk, Tanperati chanm |
|
COA/ROS/MSDS/MOA |
Bay |
Aplikasyon
1-3-Methoxyphenylpiperazinedihydrochloride (MeOPP) se yon dwòg ki ka itilize pou etidye nerotransmeteur ki pa klasik nan sistèm nerotransmetè a, tankou isoproterenolamin ak triptofan. Anplis de sa, MeOPP ka itilize tou pou etidye efè dwòg sou reseptè nerotransmeteur yo.
1-(3-Methoxyphenyl)piperazine Dihydrochloride se yon entèmedyè nanLetermovir, non komèsPrevymisse yon dwòg antiviral pou tretman enfeksyon cytomegalovirus (CMV). Li te teste nan pasyan CMV ki enfekte ak transplantasyon selil souch allojenik epi li ka itil tou pou lòt pasyan ki gen yon sistèm iminitè konpwomèt tankou moun ki gen transplantasyon ògàn oswa enfeksyon VIH. Te dwòg la okòmansman devlope pa divizyon anti-enfektye nan Bayer, ki te vin AiCuris Anti-infective Cures AG atravè yon spin-out epi li te pwogrese devlopman nan fen Faz 2 anvan pwojè a te vann bay Merck & Co pou devlopman ak apwobasyon Faz 3.
Ajans Medikaman Ewopeyen an te akòde dwòg la akòde estati Fast Track pa US Food and Drug Administration (FDA) ak estati dwòg òfelen pa Ajans Medikaman Ewopeyen an. Kounye a li apwouve pou prevansyon enfeksyon CMV ak maladi nan moun k ap resevwa yon transplantasyon selil souch allojenik.
Estrikti konpayi




POUKISA CHWAZI NOU


Mo kle yo
1-(3-Metoksifenil)piperazin,CAS 16015-71-7
1-(3-Metoksifenil)piperazin dihydrochloride,CAS 6968-76-9
Baj popilè: 1-(3-methoxyphenyl)piperazine dihydrochloride, Lachin 1-(3-methoxyphenyl)piperazine dihydrochloride founisè, faktori











